These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1759226)

  • 21. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of immune cholesterol as a marker for atherosclerosis.
    Orekhov AN; Kalenich OS; Tertov VV; Perova NV; Novikov IyD ; Lyakishev AA; Deev AD; Ruda MYa
    J Cardiovasc Risk; 1995 Oct; 2(5):459-66. PubMed ID: 8749274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol content of circulating immune complexes in patients with coronary stenosis and subjects without evidence of atherosclerosis.
    Lecomte E; Herbeth B; Clerc G; Khalife K; Siest G; Artur Y
    Clin Chem; 1995 Oct; 41(10):1526-31. PubMed ID: 7586529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regression and therapy of atherosclerosis: regression of atherosclerosis under anti-cholesterol therapy].
    Yamamoto A
    Nihon Rinsho; 1988 Mar; 46(3):686-93. PubMed ID: 3404696
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cholesterol-containing circulating immune complexes in patients with cerebral arteriosclerosis and disorders of cerebral circulation].
    Akopov SE; Nazarian AV; Tunian IuS; Gabrielian ES
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(7):50-2. PubMed ID: 1661482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherosclerosis in relation to cholelithiasis and cholesterolosis.
    Záhor Z
    Bull World Health Organ; 1976; 53(5-6):531-7. PubMed ID: 1087192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol level in circulating immune complexes as a marker of coronary atherosclerosis.
    Orekhov AN; Kalenich OS; Tertov VV; Novikov ID; Vorob'eva EG
    Adv Exp Med Biol; 1991; 285():393-7. PubMed ID: 1858572
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries.
    Plachta H; Bartnikowska E; Obara A
    Clin Chim Acta; 1992 Oct; 211(1-2):101-12. PubMed ID: 1468149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coronary atherosclerosis.
    Gallino A; Aboyans V; Diehm C; Cosentino F; Stricker H; Falk E; Schouten O; Lekakis J; Amann-Vesti B; Siclari F; Poredos P; Novo S; Brodmann M; Schulte KL; Vlachopoulos C; De Caterina R; Libby P; Baumgartner I;
    Eur Heart J; 2014 May; 35(17):1112-9. PubMed ID: 24595865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis].
    Kalenich OS; Tertov VV; Novikov ID; Vorob'eva EG; Perova NV; Metel'skaia VA; Pomerantsev EV; Liakishev AA; Ruda MIa; Orekhov AN
    Kardiologiia; 1991 Feb; 31(2):42-4. PubMed ID: 2041290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistin is independently associated with abdominal aortic aneurysm in severe coronary artery disease patients.
    Elkalioubie A; Juthier F; Gautier C; Vincentelli A; Pinet F; Jude B; Dupont A
    Cardiovasc Pathol; 2012; 21(2):e27-9. PubMed ID: 21798767
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral artery disease in patients with coronary artery disease.
    Atmer B; Jogestrand T; Laska J; Lund F
    Int Angiol; 1995 Mar; 14(1):89-93. PubMed ID: 7658111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis.
    Momiyama Y; Ohmori R; Fayad ZA; Kihara T; Tanaka N; Kato R; Taniguchi H; Nagata M; Nakamura H; Ohsuzu F
    Atherosclerosis; 2010 Jun; 210(2):668-70. PubMed ID: 20074733
    [No Abstract]   [Full Text] [Related]  

  • 34. Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions?
    Stein Y; Stein O
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):183-8. PubMed ID: 11156850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of the relation between lipoprotein(a) and lipids for development of atherosclerosis and cardiovascular disease.
    Dahlén GH; Ekstedt B
    J Intern Med; 2001 Sep; 250(3):265-7. PubMed ID: 11555135
    [No Abstract]   [Full Text] [Related]  

  • 36. Earlobe crease and atherosclerosis. An autopsy study.
    Ishii T; Asuwa N; Masuda S; Ishikawa Y; Shimada K; Takemoto S
    J Am Geriatr Soc; 1990 Aug; 38(8):871-6. PubMed ID: 2095754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging of peripheral vascular disease. The state of the artery.
    Mohiaddin RH
    Echocardiography; 1992 Sep; 9(5):553-77. PubMed ID: 10147795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture.
    Tertov VV; Orekhov AN; Sayadyan KS; Serebrennikov SG; Kacharava AG; Lyakishev AA; Smirnov VN
    Atherosclerosis; 1990 Apr; 81(3):183-9. PubMed ID: 2350370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isolation of immune complexes from the vascular wall in experimental immunovasculitis].
    Bucsky P; Jörg M
    Morphol Igazsagugyi Orv Sz; 1979 Oct; 19(4):267-70. PubMed ID: 530285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma phosphatides in arteriosclerotic occlusions in the arteries of extremities].
    Jipp P
    Dtsch Med Wochenschr; 1969 Mar; 94(11):530-4. PubMed ID: 5766154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.